148 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Seidman
    Seidman
  4. Zelenetz
    Zelenetz
  5. Kelsen
    Kelsen
  6. Moskowitz
    Moskowitz
  7. Noy
    Noy
  8. Panageas
    Panageas
  9. Hensley
    Hensley
  10. Moore
    Moore

Groups

  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (70)
  3. Hematologic Malignancies, Division of (39)
  4. Survivorship Research (37)
  5. Breast Medicine Service (32)
  6. Center for Hematologic Malignancies (30)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  8. Biostatistics Service (26)
  9. Epidemiology and Biostatistics (26)
  10. Nursing (19)
  1. "recombinant granulocyte colony stimulating factor"
Formats
  1. Journal Article (143)
  2. Conference Paper (5)
Groups
  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (70)
  3. Hematologic Malignancies, Division of (39)
  4. Survivorship Research (37)
  5. Breast Medicine Service (32)
  6. Center for Hematologic Malignancies (30)

More Groups

People
  1. Clifford Hudis (19)
  2. Larry Norton (19)
  3. Andrew Seidman (14)
  4. Andrew Zelenetz (12)
  5. Craig Moskowitz (10)
  6. David Kelsen (10)

More People

Years
  1. 2024 (1)
  2. 2015 (2)
  3. 2014 (3)
  4. 2013 (4)
  5. 2012 (5)
  6. 2011 (10)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Cancer (14)
  3. Clinical Breast Cancer (6)
  4. Seminars in Oncology (6)
  5. Blood (5)
  6. Gynecologic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Elsevier Inc. (27)
  3. Wiley Blackwell (16)
  4. Springer (11)
  5. Oxford University Press (9)
  6. Nature Publishing Group (7)

More Publishers

Results (148)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized ewing sarcoma: A report from the children's oncology group
    Journal Article

    Womer, R. B.; West, D. C.; Krailo, M. D.; Dickman, P. S.; Pawel, B. R.; Grier, H. E.; Marcus, K.; Sailer, S.; Healey, J. H.; Dormans, J. P.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Acute lymphoblastic leukemia: Clinical practice guidelines in oncology
    Journal Article

    Alvarnas, J. C.; Brown, P. A.; Aoun, P.; Ballen, K. K.; Bellam, N.; Blum, W.; Boyer, M. W.; Carraway, H. E.; Coccia, P. F.; Coutre, S. E.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Durable remission with salvage second autotransplants in patients with multiple myeloma
    Journal Article

    Shah, N.; Ahmed, F.; Bashir, Q.; Qureshi, S.; Dinh, Y.; Rondon, G.; Wen, S.; Thall, P.; Khan, H.; Giralt, S.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma
    Journal Article

    Bashir, Q.; Shah, N.; Parmar, S.; Wei, W.; Rondon, G.; Weber, D. M.; Wang, M.; Orlowski, R. Z.; Thomas, S. K.; Shah, J.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): A phase 3 biological assignment trial
    Journal Article

    Krishnan, A.; Pasquini, M. C.; Logan, B.; Stadtmauer, E. A.; Vesole, D. H.; Alyea, E.; Antin, J. H.; Comenzo, R.; Goodman, S.; Hari, P.; more...
    Lancet Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer
    Journal Article

    Konner, J. A.; Grabon, D. M.; Gerst, S. R.; Iasonos, A.; Thaler, H.; Pezzulli, S. D.; Sabbatini, P. J.; Bell-Mcguinn, K. M.; Tew, W. P.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • NCCN biosimilars white paper: Regulatory, scientific, and patient safety perspectives
    Journal Article

    Zelenetz, A. D.; Ahmed, I.; Braud, E. L.; Cross, J. D.; Davenport-Ennis, N.; Dickinson, B. D.; Goldberg, S. E.; Gottlieb, S.; Johnson, P. E.; Lyman, G. H.; more...
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save
  • Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: Long-term follow-up of US intergroup study E2997
    Journal Article

    Smith, M. R.; Neuberg, D.; Flinn, I. W.; Grever, M. R.; Lazarus, H. M.; Rowe, J. M.; Dewald, G.; Bennett, J. M.; Paietta, E. M.; Byrd, J. C.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy
    Journal Article

    Morris, P. G.; Abrey, L. E.; Reiner, A. S.; Wu, N.; Panageas, K. S.; Seko, B. S.; Deangelis, L. M.; Omuro, A.
    Leukemia and Lymphoma (2011)

    Fulltext@MSK | Save